T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II...
HTX Approved for Pakistan Crypto Exchange Registration
ISLAMABAD, Pakistan, Dec. 12, 2025 /PRNewswire/ -- HTX, one of the world's leading digital asset exchanges with over 50 million registered users globally, today announced that it has officially obtained a No Objection Certificate (NoC) from the...
Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru
First cyclotron outside Klang Valley to anchor Malaysia's advanced cancer care ecosystem KEY-HIGHLIGTHS RM500 million investment in advanced cancer care infrastructure State-of-the-art diagnostic and treatment facilities, including a nuclear...
EQT to invest USD 930 million in Douzone Bizon, a leading provider of ERP and software solutions in South Korea
EQT signs SPA to invest in Douzone Bizon, a provider of ERP and software solutions in South Korea EQT plans to acquire a 37.6% stake in Douzone Bizon, including shares held by majority shareholder, Chairman Young-woo Kim, and other major...
TOYO Co., Ltd Announces Plans for Additional 2GW Solar Cell Capacity Expansion in Ethiopia
TOKYO, March 26, 2025 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF) ("TOYO" or the "Company"), a solar solution company, is excited to announce it will begin building an additional 2 gigawatts (GW) expansion of its solar cell capacity at...